Fundraising FoxOssianix
1 known investors
Find your way into Ossianix
Sign up to see every warm intro you have to Ossianix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ossianix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ossianix develops TXP1, a brain-selective shuttle based on a deimmunised VNAR antibody scaffold that targets TfR1 to carry therapeutic payloads across the blood-brain barrier. The company focuses on improving delivery of central nervous system therapeutics to the brain.
Founders & leadership
Investors · 1
In the news
Frequently asked questions
- What does Ossianix do?
- Ossianix develops TXP1, a brain-selective shuttle based on a deimmunised VNAR antibody scaffold that targets TfR1 to carry therapeutic payloads across the blood-brain barrier. The company focuses on improving delivery of central nervous system therapeutics to the brain.
- Who founded Ossianix?
- Ossianix was founded by Frank S Walsh, J Lynn Rutkowski.
- Who are Ossianix's investors?
- Ossianix's investors include BioAdvance.